AngioDynamics Receives 510(k) Clearance for AlphaVac F1885 System in Treatment of PE
April 4, 2024
New Indication for Treatment of Pulmonary Embolism Enhances Device Utility in Critical Medical Scenarios
New Indication for Treatment of Pulmonary Embolism Enhances Device Utility in Critical Medical Scenarios
This method of use patent award marks a major achievement for the Company and follows another recent patent covering our core technology.
The clearance adds to the list of devices the FDA has authorized this year with AI algorithms to detect health conditions.
The CEO of Prenosis told MedTech Dive the company sees third-party validation as important, with the FDA having clarified that certain decision support tools should be regulated as medical devices.
The low-cost hardware outperforms state-of-the-art versions and could someday enable an affordable, in-home device for health monitoring.
TEG testing provides critical information that can help physicians improve hemostasis management for their patients
HeadaTerm 2 uses neuromodulation technology. It releases targeted electrical impulses that increase the pain tolerance of the wearer.
The Venus Versa Pro combines the applicator of the Venus Viva MD with the Venus Versa system which are both approved in Australia and registered in Australian Register of Therapeutic Goods (ARTG).
This milestone gives healthcare professionals an important tool for managing bacteremia by providing antibiotic susceptibility test (AST) results with unprecedented speed.
“This really is a landmark moment and we’ll be working with the NHS and others to ensure a fair rollout that reaches people as quickly as possible.”